Skip to main content
Caplight Logo









Genecis Bioindustries

Genecis Bioindustries

Private
TorontoEnergy & Sustainabilityhttps://www.genecis.co/

Last Round

Series A

Extension

Mar 1, 2023

Est. Valuation

$2.14M

Total Funding Raised

$14.83M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Genecis Bioindustries is a biotechnology company that converts organic waste into high-performance, biodegradable polyhydroxyalkanoate (PHA) bioplastics.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Biotechnology, Circular Economy, Clean Manufacturing, Waste Management

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

PHApolyhydroxyalkanoatebioplasticfood waste conversionwaste to valuebiodegradable polymercircular economycompostable plasticsustainable materialsclimate techplastic alternativefermentation technologywaste valorizationwaste upcyclingengineered bacteriacustom polymer formulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genecis Bioindustries Comparables

Compare Genecis Bioindustries with similar companies based on industry and business-model similarity.

Genecis Bioindustries comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TerraVerdae Bioworks
86%
Mango Materials
85%
Dionymer
85%

Genecis Bioindustries Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMar 1, 2023
DebtAug 4, 2022
Series AAug 4, 2022
GrantJul 27, 2021
AcceleratorMar 1, 2020
Grant
Jan 2, 2020

Key People

Founding team and executive leadership

Brad Witt

Chief Financial Officer

Executive Team

Genecis Bioindustries Investors

Notable investors and investment history

Genecis Bioindustries investors
InvestorRounds
IT-Farm CorporationSeries A
Khosla VenturesSeries A Extension, Series A
Business Development Bank of Canada (BDC Capital)Series A Extension
Re:foodSeries A
Emerald Technology VenturesSeries A Extension
BDC CapitalSeries A, Series A Extension
Government of CanadaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 219% MoM, reaching 2.4K.

  • Jun 20, 2026

    Monthly visitors increased 391% MoM.

Genecis Bioindustries Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genecis Bioindustries Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genecis Bioindustries's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range13
Year Founded2017
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?